Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s share price traded up 6.7% on Friday . The company traded as high as GBX 8 ($0.10) and last traded at GBX 8 ($0.10). 82,534 shares were traded during mid-day trading, a decline of 75% from the average session volume of 326,406 shares. The stock had previously closed at GBX 7.50 ($0.10).
Ondine Biomedical Trading Up 6.7 %
The business’s 50-day moving average price is GBX 7.47 and its 200 day moving average price is GBX 8.81. The company has a market cap of £22.18 million, a P/E ratio of -133.33 and a beta of -0.01. The company has a debt-to-equity ratio of 24.39, a quick ratio of 8.26 and a current ratio of 2.34.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Read More
- Five stocks we like better than Ondine Biomedical
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 5/20 – 5/24
- Why Are Stock Sectors Important to Successful Investing?
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- What Are Dividend Achievers? An Introduction
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
